Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("VAN GORP, E. C. M")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 13 of 13

  • Page / 1
Export

Selection :

  • and

Rational antithrombotic therapy and prophylaxis in elderly, immobile patientsVAN GORP, E. C. M; BRANDJES, D. P. M; TEN CATE, J. W et al.Drugs & aging. 1998, Vol 13, Num 2, pp 145-157, issn 1170-229XArticle

Effect of HIV viral load, CD4 cell count and antiretroviral therapy on human papillomavirus prevalence in urine samples of HIV-infected menJONG, E; VAN GORP, E. C. M; MULDER, J. W et al.International journal of STD & AIDS. 2009, Vol 20, Num 4, pp 262-264, issn 0956-4624, 3 p.Article

Population pharmacokinetics of lopinavir in combination with ritonavir in HIV-1-infected patientsCROMMENTUYN, K. M. L; KAPPELHOFF, B. S; MULDER, J. W et al.British journal of clinical pharmacology. 2005, Vol 60, Num 4, pp 378-389, issn 0306-5251, 12 p.Article

An unusual cause of a usual presentationGOEIJENBIER, M; NUR, E; GORIS, M et al.Netherlands journal of medicine. 2011, Vol 69, Num 6, issn 0300-2977, 285, 289 [2 p.]Article

Procalcitonin as a potent marker of bacterial infection in febrile Afro-Caribbean patients at the emergency departmentLIMPER, M; DE KRUIF, M. D; AJUBI, N. E et al.European journal of clinical microbiology & infectious diseases (Print). 2011, Vol 30, Num 7, pp 831-836, issn 0934-9723, 6 p.Article

Identification and Profiling of Circulating Metabolites of Atazanavir, a HIV Protease InhibitorTER HEINE, R; HILLEBRAND, M. J. X; ROSING, H et al.Drug metabolism and disposition. 2009, Vol 37, Num 9, pp 1826-1840, issn 0090-9556, 15 p.Article

Quantification of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography-triple quadrupole mass spectrometryTER HEINE, R; ROSING, H; VAN GORP, E. C. M et al.Journal of chromatography. B. 2008, Vol 867, Num 2, pp 205-212, issn 1570-0232, 8 p.Article

What role do coagulation disorders play in the pathogenesis of leptospirosis?WAGENAAR, J. F. P; GORIS, M. G. A; SAKUNDARNO, M. S et al.TM & IH. Tropical medicine & international health. 2007, Vol 12, Num 1, pp 111-122, issn 1360-2276, 12 p.Article

One-year epidemiology of fever at the Emergency DepartmentLIMPER, M; EEFTINCK SCHATTENKERK, D; DE KRUIF, M. D et al.Netherlands journal of medicine. 2011, Vol 69, Num 3, pp 124-128, issn 0300-2977, 5 p.Article

Effects of a 3-month course of rosuvastatin in patients with systemic lupus erythematosusDE KRUIF, M. D; LIMPER, M; HANSEN, H. R et al.Annals of the rheumatic diseases. 2009, Vol 68, Num 10, issn 0003-4967, p. 1654Article

Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometryTER HEINE, R; HILLEBRAND, M. J. X; ROSING, H et al.Journal of pharmaceutical and biomedical analysis. 2009, Vol 49, Num 2, pp 451-458, issn 0731-7085, 8 p.Article

Evaluation of clinical pharmacist interventions on drug interactions in outpatient pharmaceutical HIV-careDE MAAT, M. M. R; DE BOER, A; KOKS, C. H. W et al.Journal of clinical pharmacy and therapeutics (Print). 2004, Vol 29, Num 2, pp 121-130, issn 0269-4727, 10 p.Article

Review : Infectious diseases and coagulation disordersVAN GORP, E. C. M; SUHARTI, C; TEN CATE, H et al.The Journal of infectious diseases. 1999, Vol 180, Num 1, pp 176-186, issn 0022-1899Article

  • Page / 1